---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-031997"
form_type: "8-K/A"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2022-09-01T23:59:59+00:00"
generated_at: "2026-06-23T18:08:52.192077+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Brooklyn ImmunoTherapeutics CSO Kevin D'Amour resigns; separation agreement provides $311K severance

## Summary
- Dr. Kevin D'Amour's resignation as Chief Scientific Officer effective August 26, 2022.
- Separation agreement includes 9 months' base salary totaling $311,250 (less withholdings).
- Vested options on 57,296 shares exercisable for 90 days post-separation; all unvested equity forfeited.
- COBRA health premium paid for the 9-month severance period.
- D'Amour agrees to cooperation, non-disparagement, and a general release of claims.

## SEC filing metadata
- accession: 0001140361-22-031997
- form_type: 8-K/A
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2022-09-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000114036122031997/0001140361-22-031997-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000114036122031997/brhc10041542_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-031997
- JSON: https://secwatch.observer/filing/0001140361-22-031997.json
- Plain text: https://secwatch.observer/filing/0001140361-22-031997.txt

## Key facts
- Executive change
  Kevin D'Amour resigned as Chief Scientific Officer at Ernexa Therapeutics Inc..
  - Action: resigned
  - Role: Chief Scientific Officer
  source text: On July 21, 2022, Dr. Kevin D’Amour, Chief Scientific Officer of Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (the “ Company ”), delivered his notice of resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000114036122031997/0001140361-22-031997-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.